Literature DB >> 19063940

The Klotho gene family as a regulator of endocrine fibroblast growth factors.

Hiroshi Kurosu1, Makoto Kuro-O.   

Abstract

The Klotho gene encodes a single-pass transmembrane protein and functions as an aging-suppressor gene, which extends lifespan when overexpressed and accelerates the development of aging-like phenotypes when disrupted in mice. Fibroblast growth factor 23 (FGF23) is a bone-derived hormone that regulates phosphate and vitamin D homeostasis. It has been shown that Klotho-deficient mice and Fgf23 knockout mice exhibit identical phenotypes. This observation led to the identification of Klotho as a cofactor essential for interactions between FGF23 and FGF receptors. In addition to the Klotho-FGF23 axis, recent studies has shown that betaKlotho, a Klotho family protein, also functions as a cofactor required for FGF19 and FGF21 signaling and determines the tissue-specific metabolic activities of FGF19 and FGF21. This review summarizes recent progress in understanding of Klotho and betaKlotho function in the regulation of tissue-specific metabolic activity of the endocrine fibroblast growth factors (FGF19, FGF21, and FGF23).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19063940     DOI: 10.1016/j.mce.2008.10.052

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  59 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

2.  Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.

Authors:  Ming-Chang Hu; Mingjun Shi; Jianning Zhang; Henry Quiñones; Makoto Kuro-o; Orson W Moe
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

Review 3.  The role of Klotho in energy metabolism.

Authors:  M Shawkat Razzaque
Journal:  Nat Rev Endocrinol       Date:  2012-05-29       Impact factor: 43.330

Review 4.  Recent advances in renal phosphate handling.

Authors:  Emily G Farrow; Kenneth E White
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

5.  FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.

Authors:  Xinle Wu; Hongfei Ge; Bryan Lemon; Steven Vonderfecht; Jennifer Weiszmann; Randy Hecht; Jamila Gupte; Todd Hager; Zhulun Wang; Richard Lindberg; Yang Li
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

Review 6.  Klotho: An Elephant in Aging Research.

Authors:  Amin Cheikhi; Aaron Barchowsky; Amrita Sahu; Sunita N Shinde; Abish Pius; Zachary J Clemens; Hua Li; Charles A Kennedy; Joerg D Hoeck; Michael Franti; Fabrisia Ambrosio
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-06-18       Impact factor: 6.053

Review 7.  Fibroblast growth factor 21: from pharmacology to physiology.

Authors:  Steven A Kliewer; David J Mangelsdorf
Journal:  Am J Clin Nutr       Date:  2009-11-11       Impact factor: 7.045

8.  Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.

Authors:  John R Montford; Michel Chonchol; Alfred K Cheung; James S Kaufman; Tom Greene; William L Roberts; Gerard Smits; Jessica Kendrick
Journal:  Am J Nephrol       Date:  2013-02-20       Impact factor: 3.754

9.  Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression.

Authors:  Shu Feng; Olga Dakhova; Chad J Creighton; Michael Ittmann
Journal:  Cancer Res       Date:  2013-02-25       Impact factor: 12.701

Review 10.  Overview of the FGF23-Klotho axis.

Authors:  Makoto Kuro-o
Journal:  Pediatr Nephrol       Date:  2009-07-22       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.